OMB APPROVAL
OMB NUMBER: 3235-0145
EXPIRES: AUGUST 31, 1991
ESTIMATED AVERAGE BURDEN
HOURS PER RESPONSE.........14.90
--------------------------------
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13D
UNDER THE SECURITIES EXCHANGE ACT OF 1934
Harvard Scientific Corporation
(Name of Issuer)
Common Stock
(Title of Class of Securities)
417465 20 0
(CUSIP Number)
Thomas E. Waite, President and Chief Executive Officer
106 Ridge Road, Lake Mary, Florida, 32746
(Name, Address and Telephone Number of Person Authorized to Receive Notices
and Communications)
11/14/97
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report
the acquisition which is the subject of this Schedule 13D, and is filing this
schedule because of Rule 13d-1(b)(3) or (4), check the following box / /.
Check the following box if a fee is being paid with the statement / /. (A fee is
not required only if the reporting person: (1) has a previous statement on file
reporting beneficial ownership of more than five percent of the class of
securities described in Item 1; and (2) has filed no amendment subsequent
thereto reporting beneficial ownership of five percent or less of such class.)
(See Rule 13d-7.)
NOTE: Six copies of this statement, including all exhibits, should be filed with
the Commission. See Rule 13d1(a) for other parties to whom copies are to be
sent.
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
<PAGE>
SCHEDULE 13D
CUSIP NO. 417465 20 0 PAGE 2 OF 4 PAGES
--------------- ----- -------
- ------------------------- ---------------------------
- ------ ------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Thomas E. Waite
- ------ ------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a)[ ]
(b)[ ]
- ------ ------------------------------------------------------------------------
3 SEC USE ONLY
- ------ ------------------------------------------------------------------------
4 SOURCE OF FUNDS*
SC
- ------ ------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDING IS REQUIRED PURSUANT TO
ITEMS 2(d) or 2(E) / /
- ------ ------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
USA
- ------ ------------------------------------------------------------------------
7 SOLE VOTING POWER
NUMBER OF
SHARES 4,000,000
BENEFICIALLY ---- -----------------------------------------------
OWNED BY
EACH 8 SHARED VOTING POWER
REPORTING
PERSON 0
WITH ---- -----------------------------------------------
9 SOLE DISPOSITIVE POWER
4,000,000
---- -----------------------------------------------
10 SHARED DISPOSITIVE POSER
0
- ------ ------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
4,000,000
- ------ ------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
[ ]
- ------ ------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
30%
- ------ ------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
IN
- ------ ------------------------------------------------------------------------
<PAGE>
*SEE INSTRUCTIONS BEFORE FILLING OUT!
ITEM 1. SECURITY AND ISSUER
Title of the class of equity securities: Harvard Scientific Corporation Common
stock.
Address of Issuer: Havard Scientific Corporation, 1601 E. Flamingo, Ste 18, Las
Vegas, NV, 89119
ITEM 2. IDENTITY AND BACKGROUND
(a) Name: Thomas E. Waite
(b) Residence or business address: 106 Ridge Road, Lake Mary, Florida,
32746
(c) Present principal occupation or employment: President, CEO, Harvard
Scientific Corp.
(d) No
(e) No
(f) U.S.
ITEM 3. SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION
The Company issued to Mr. Waite 4,000,000 shares of Common Stock of the
Company upon Mr. Waite's appointment as President, Chief Executive Officer and
Chairman of the Board of Directors of the Company
ITEM 4. PURPOSE OF TRANSACTION
Mr. Waite acquired the Common Stock in connection with his employment by
the Company.
(a) No plans (g) No Changes
(b) No plans (h) No plans
(c) No plans (i) None
(d) Mr. Waite has become President, CEO and Chairman of the Company. Mr.
Waite currently has no plans to further change the Company's
management or Board of Directors.
(e) No plans (j) None
(f) No plans
3
<PAGE>
ITEM 5. INTEREST IN SECURITIES OF THE ISSUER
(a) Mr. Waite beneficially owns 4,000,000 shares of Common Stock, or 30.0%
of the outstanding Common Stock of the Company.
(b) Mr. Waite has the sole power to vote 4,000,000 shares of Common Stock
of the Company, or 30% of the Common Stock of the Company.
(c) During the last sixty days, Mr. Waite has not completed any
transactions in the Common Stock of the Company.
(d) No such person exists.
(e) Not applicable.
ITEM 6. CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIPS WITH RESPECT TO
SECURITIES OF THE ISSUER.
None.
ITEM 7. MATERIAL TO BE FILED AS EXHIBITS
None.
SIGNATURES
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true complete and
correct.
BY: /s/ Thomas E. Waite 11/19/97
--------------------------------
Thomas E. Waite
4
